Extrait

•To evaluate the safety and reactogenicity of one or two doses of the TB vaccine candidate (M72/AS01E) when given to healthy infants concomitantly with the Expanded Programme on Immunisation (EPI) regimen containing DTPwHepB/Hib + pneumococcal conjugate vaccine (PCV) + oral polio vaccine (OPV). •To evaluate the safety and reactogenicity of one or two doses of the TB vaccine candidate (M72/AS01E) when given to healthy infants after receiving the EPI vaccines containing DTPwHepB/Hib+PCV+OPV.

Critère d'inclusion

• Healthy volunteers (evaluation of safety and reactogenicity of TB vaccine when administered in healthy infants)

Liens

• gsk
• euctr